Evonik is one of the world's leading specialty chemicals companies. Profitable growth and a sustained increase in the value of the company form the heart of their strategy, which is supported by their owners, RAG-Stiftung (74.99 percent) and funds managed by CVC Capital Partners (25.01 percent).

Their specialty chemicals activities focus on high-growth megatrends—especially health, nutrition, resource efficiency, and globalisation—and their goal is to enter attractive future-oriented markets.

In 2011 Evonik's roughly 33,000 employees generated sales of €14.5 billion and an operating result (EBITDA) of €2.8 billion. More than 70 percent of sales are generated outside Germany, providing convincing evidence that our business is global.

 

Visit the website HERE.

Evonik'S PROFILE

You might also like

Latest Videos

Leave A Comment

Don’t worry ! Your email address will not be published. Required fields are marked (*).

ADVERTISING

DOWNLOAD OUR APP

QR Code

ADVERTISING